HAC (Russian)
RSCI (Russian)
Ulrichsweb (Ulrich’s Periodicals Directory)
Scientific Indexing Services

Features of the etiology and pathogenesis of chronic heart failure in patients of older age groups

DOI: https://doi.org/10.29296/25877305-2022-06-02

А. Yakovlev, Candidate of Medical Sciences
Saint Petesburg Institution of Bioregulation and Gerontology
Saint Petersburg City Multiprofile hospital Second
Saint Petersburg State Medical University

The review presents a literature analysis on the most frequent reasons of chronic heart failure in elderly and senile age groups. The features of the pathogenesis of the disease in the elderly and senile age are described.

chronic heart failure
elderly and senile

  1. Tsao C.W., Lyass A., Enserro D. et al. Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction. JACC: Heart Fail. 2018; 6 (8): 678–85. DOI: 10.1016/j.jchf.2018.03.006
  2. Vinogradova N.G., Polyakov D.S., Fomin I.V. Analysis of mortality in patients with heart failure after decompensation during long-term follow-up in specialized medical care and in real clinical practice. Kardiologiia. 2020; 60 (4): 91–100 (in Russ.). DOI: 10.18087/cardio.2020.4.n1014
  3. Shah K.S., Xu H., Matsouaka R.A. Heart Failure with Preserved, Borderline, and Reduced Ejection Fraction. J Am Coll Cardiol. 2017; 70 (20): 2476–86. DOI: 10.1016/j.jacc.2017.08.074
  4. Smith W.M. Epidemiology of congestive heart failure. Am J Cardiol. 1985; 55 (2): 3A-8A. DOI: 10.1016/0002-9149(85)90789-1
  5. Gibson T.C., White K.L., Klainer L.M. The prevalence of congestive heart failure in two rural communities. J Chronic Dis. 1966; 19 (2): 141–52. DOI: 10.1016/0021-9681(66)90045-2
  6. Kalon K.L., Pinsky J.L., Kannel W.B. et al. The epidemiology of heart failure: Framingham Study. J Am Coll Cardiol. 1993; 22 (4): 6A-13A. DOI: 10.1016/0735-1097(93)90455-A
  7. Mahmood S.S., Wang T.J. The epidemiology of congestive heart failure: the Framingham Heart Study perspective. Global Heart. 2013; 8 (1): 77–82. DOI: 10.1016/j.gheart.2012.12.006
  8. Cybulska B., Kłosiewicz-Latoszek L. Landmark studies in coronary heart disease epidemiology. The Framingham Heart Study after 70 years and the Seven Countries Study after 60 years. Kardiol Pol. 2019; 77 (2): 173–80. DOI: 10.5603/KP.a2019.0017
  9. Ho K.K., Pinsky J.L., Kannel W.B. et al. The epidemiology of heart failure: Framingham Study. J Am Coll Cardiol. 1993; 4: 6A-13A. DOI: 10.1016/0735-1097(93)90455-a
  10. Sutton G.C. Epidemiologic aspects of heart failure. Am Heart J. 1990; 120 (6): 1538–40. DOI: 10.1016/0002-8703(90)90055-3
  11. Sciomer S., Moscucci F., Salvioni E. et al. Role of gender, age and BMI in prognosis of heart failure. Eur J Prev Cardiol. 2020; 27 (2): 46–51. DOI: 10.1177/2047487320961980
  12. Swedberg K., Cleland J., Dargie H. et al. Diagnosis and treatment of chronic heart disease. Guidelines of the European Society of Cardiology. Revision 2005. Kardiol Pol. 2005; 63 (5): 509–43.
  13. Solal A.C., Tournoux F., Beauvais F. et al. Comment évaluer et traiter l’insuffisance cardiaque à fraction d’éjection préservée. Therapie. 2009; 64 (2): 101–9 (in French). DOI: 10.2515/therapie/2009012
  14. Göbel S., Hobohm L., Ostad M.A. et al. Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany. Prog Cardiovasc Dis. 2020; 63 (5): 591–8. DOI: 10.1016/j.pcad.2020.03.013
  15. Klein L., Grau-Sepulveda M.V., Bonow R.O. et al. Quality of care and outcomes in women hospitalized for heart failure. Circulation. Heart Fail. 2011; 4 (5): 589–98. DOI: 10.1161/CIRCHEARTFAILURE.110.960484
  16. Scardovi A.B., Petruzzi M., Rosano A. et al. Heart failure phenotype in women. Giornale italiano di cardiologia (Rome). 2012; 13 (1): 6S-11S.
  17. Crousillat D.R., Ibrahim N.E. Sex Differences in the Management of Advanced Heart Failure. Curr Treat Options Cardiovasc Med. 2018; 20 (11): 88. DOI: 10.1007/s11936-018-0687-y
  18. Nesterov V.S., Urvantseva I.A., Vorobev A.S. Chronic heart failure: modern problems and their solutions. Lechaschi Vrach. 2018; 7: 11–4 (in Russ.).
  19. Polyakov D.S., Fomin I.V., Belenkov Yu.N. et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021; 61 (4): 4–14 (in Russ.). DOI: 10.18087/cardio.2021.4.n1628
  20. Ponikowski P., Voors A.A., Anker S.D. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37 (27): 2129–200. DOI: 10.1093/eurheartj/ehw128
  21. Cubillos-Garzón L.A., Casas J.P., Morillo C.A. et al. Congestive heart failure in Latin America: the next epidemic. Am Heart J. 2004; 147 (3): 412–7. DOI: 10.1016/j.ahj.2003.07.026
  22. Rohde L.E., Clausell N., Ribeiro J.P. et al. Health outcomes in decompensated congestive heart failure: a comparison of tertiary hospitals in Brazil and United. Int J Cardiol. 2005; 102 (1): 71–7. DOI: 10.1016/j.ijcard.2004.04.006
  23. Orso F., Fabbri G., Maggioni A.P. Epidemiology of Heart Failure. Handb Exp Pharmacol. 2017; 243: 15–33. DOI: 10.1007/164_2016_74
  24. Špinar J., Špinarová L., Vitovec J. Pathophysiology, causes and epidemiology of chronic heart failure. Vnitr Lek. 2018; 64 (9): 834–8.
  25. Cook C., Cole G., Asaria P. et al. The annual global economic burden of heart failure. Int J Cardiol. 2014; 171 (3): 368–76. DOI: 10.1016/j.ijcard.2013.12.028
  26. Yingchoncharoen T., Wu T.C., Choi D.J. et al. Economic Burden of Heart Failure in Asian Countries with Different Healthcare Systems. Korean Circ J. 2021; 51 (8): 681–93. DOI: 10.4070/kcj.2021.0029
  27. Johnson N.B., Hayes L.D., Brown K. et al. Centers for Disease Control and Prevention (CDC). CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors-United States, 2005–2013. MMWR Suppl. 2014; 63 (4): 3–27.
  28. Dharmarajan K., Rich M.W. Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults. Heart Fail Clin. 2017; 13 (3): 417–26. DOI: 10.1016/j.hfc.2017.02.001.
  29. Bories M.C., Bialobroda J., Bichara E. et al. Congestive heart failure in adults. Rev Prat. 2021; 71 (1): e3-e10. URL: https://www.researchgate.net/publication/352881365
  30. Boytsov S.A., Balanova Yu.A., Shalnova S.A. et al. Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control. by the data from ECCD. Cardiovascular Therapy and Prevention. 2014; 13 (4): 4–14 (in Russ.). DOI: 10.15829/1728-8800-2014-4-4-14
  31. Gerber Y., Weston S.A., Enriquez-Sarano M. et al. Mortality associated with heart failure after myocardial infarction: a contemporary community perspective. Circulation. Heart Fail. 2016; 9 (1): e002460-e002460. DOI: 10.1161/circheartfailure.115.002460
  32. Xanthakis V., Enserro D.M., Larson M.G. et al. Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the Community. JACC: Heart Fail. 2016; 4 (10): 808–15. DOI: 10.1016/j.jchf.2016.05.001
  33. Benjamin E.J., Muntner P., Alonso A. et al. Heart Disease and Stroke Statistics–2019 Update: A Report from the American Heart Association. Circulation. 2019; 139 (10): e56-e528. DOI: 10.1161/CIR.0000000000000659
  34. CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316 (23): 1429–35. DOI: 10.1056/NEJM198706043162301
  35. DeVore A.D., Thomas L., Albert N.M. et al. Change the management of patients with heart failure: Rationale and design of the CHAMP-HF registry. Am Heart J. 2017; 189: 177–83. DOI: 10.1016/j.ahj.2017.04.010.
  36. Komajda M., Böhm M., Borer J.S. et al. Incremental benefit of drug therapies for chronic heart failure with reduced ejection fraction: a network meta-analysis. Eur J Heart Fail. 2018; 20 (9): 1315–22. DOI: 10.1002/ejhf.1234
  37. Gelbrich G., Störk S., Kreißl-Kemmer S. et al. Effects of structured heart failure disease management on mortality and morbidity depend on patients’ mood: results from the Interdisciplinary Network for Heart Failure Study: Effects of structured HF management depend on patients’ mood. Eur J Heart Fail. 2014; 16 (10): 1133–41. DOI: 10.1002/ejhf.150
  38. Bragazzi N.L., Zhong W., Shu J. et al. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021; 28 (15): 1682–90. DOI: 10.1093/eurjpc/zwaa147
  39. Fomin I.V. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Journal of Cardiology. 2016; 8: 7–13 (in Russ.). DOI: 10.15829/1560-4071-2016-8-7-13
  40. Yancy C.W., Jessup M., Bozkurt B. et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 AC-CF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017; 136 (6): e137-e161. DOI: 10.1161/CIR.0000000000000509
  41. Groenewegen A., Rutten F.H., Mosterd A. et al. Epidemiology of heart failure. Eur J Heart Fail. 2020; 22 (8): 1342–56. DOI: 10.1002/ejhf.1858
  42. Di Tano G., De Maria R., Gonzini L. et al. The 30-day metric in acute heart failure revisited: data from IN-HF Outcome, an Italian nationwide cardiology registry. Eur J Heart Fail. 2015; 17 (10): 1032–41. DOI: 10.1002/ejhf.290
  43. Taylor C.J., Ordóñez-Mena J.M., Roalfe A.K. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000-2017: population based cohort study. BMJ. 2016; 364: l223. DOI: 10.1136/bmj.l223
  44. Berthelot E., Nouhaud C., Lafuente-Lafuente C. et al. Heart failure in patients over 80 years old. Presse Med. 2019; 48 (2): 143–53. DOI: 10.1016/j.lpm.2019.02.001
  45. Pagel P.S., Tawil J.N., Boettcher B.T. et al. Heart Failure With Preserved Ejection Fraction: A Comprehensive Review and Update of Diagnosis, Pathophysiology, Treatment, and Perioperative Implications. J Cardiothorac Vasc Anestha. 2021; 35 (6): 1839–59. DOI: 10.1053/j.jvca.2020.07.016
  46. Truby L.K., Rogers J.G. Advanced Heart Failure: Epidemiology, Diagnosis, and Therapeutic Approaches. JACC. Heart Fail. 2020; 8 (7): 523–36. DOI: 10.1016/j.jchf.2020.01.014
  47. Chaudhry S.P., Stewart G.C. Advanced Heart Failure: Prevalence, Natural History, and Prognosis. Heart Fail Clin. 2016; 12 (3): 323–33. DOI: 10.1016/j.hfc.2016.03.001
  48. Tereshchenko S.N., Zhirov I.V., Narusov O.Yu. et al. Clinical guidelines for the diagnosis and treatment of chronic and acute heart failure. Kardiologicheskij Vestnik. 2016; 2: 3–33 (in Russ.).
  49. Makowska A.M., Jorstad H.T., van den Brink R.B.A. et al. Dyspnoea. Ned Tijdschr Geneeskd. 2020; 164: D3658.
  50. Olivieri F., Recchioni R., Marcheselli F. et al. Cellular senescence in cardiovascular diseases: potential age-related mechanisms and implications for treatment. Curr Pharm Des. 2013; 19 (9): 1710–9.
  51. Dong M., Yang Z., Fang F. et al. Aging Attenuates Cardiac Contractility and Affects Therapeutic Consequences for Myocardial Infarction. Aging Dis. 2020; 11 (2): 365–76. DOI: 10.14336/AD.2019.0522
  52. Musso C.G., Oreopoulos D.G. Aging and physiological changes of the kidneys including changes in glomerular filtration rate. Nephron. Physiology. 2011; 119 (1): p1-p5. DOI: 10.1159/000328010
  53. Rowland J., Akbarov A., Maan A. et al. Tick-Tock Chimes the Kidney Clock – from Biology of Renal Ageing to Clinical Applications. Kidney Blood Press Res. 2018; 43 (1): 55–67. DOI: 10.1159/000486907
  54. Lala A., Desai A.S. The role of coronary artery disease in heart failure. Heart Fail Clin. 2014; 10 (2): 353–65. DOI: 10.1016/j.hfc.2013.10.002
  55. Jin M., Qian Z., Yin J. et al. The role of intestinal microbiota in cardiovascular disease. J Cell Mol Med. 2019; 23 (4): 2343–50. DOI: 10.1111/jcmm.14195
  56. Kulikova AN, Tolstokorov AS, Larin IV. Mönkeberg’s sclerosis: role of calcification in arterial lesions in patients with diabetes mellitus. Angiology and vascular surgery. 2020; 26 (4): 17–21 (in Russ.). DOI: 10.33529/ANGI02020406
  57. Siontis G.C.M., Overtchouk P., Cahill T.J. et al. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis. Eur Heart J. 2019; 40 (38): 3143–53. DOI: 10.1093/eurheartj/ehz275
  58. Baumgartner H., Falk V., Bax J.J. et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38 (36): 2739–91. DOI: 10.1093/eurheartj/ehx391
  59. Kumar R.K., Tandon R. Rheumatic fever & rheumatic heart disease: the last 50 years. Indian J Med Res. 2013; 137 (4): 643–58.
  60. Hung L.C., Nadia R.A Review of Acute Rheumatic Fever and Rheumatic Heart Disease Research in Malaysia. Med J Malaysia. 2016; 71 (1): 79–86.
  61. Alghamdi F., Chan M. Management of heart failure in the elderly. Curr Opin Cardiol. 2017; 32 (2): 217–23. DOI: 10.1097/HCO.0000000000000375
  62. Skrzypek A., Mostowik M., Szeliga M. et al. Chronic heart failure in the elderly: still a current medical problem. Folia Medica Cracoviensia. 2018; 58 (4): 47–56.
  63. House A.A. Management of Heart Failure in Advancing CKD: Core Curriculum 2018. Am J Kidney Dis. 2018; 72 (2): 284–95. DOI: 10.1053/j.ajkd.2017.12.006
  64. Osmanska J., Jhund P.S. Contemporary Management of Heart Failure in the Elderly. Drugs Aging. 2019; 36 (2): 137–46. DOI: 10.1007/s40266-018-0625-4
  65. Güder G., Störk S.COPD and heart failure: differential diagnosis and comorbidity. Herz. 2019; 44 (6): 502–8. DOI: 10.1007/s00059-019-4814-7
  66. Pirina P., Zinellu E., Martinetti M. et al. COPD-HF Study Group. Treatment of COPD and COPD-heart failure comorbidity in primary care in different stages of the disease. Prim Health Care Res Dev. 2020; 5 (21): e16. DOI: 10.1017/S1463423620000079
  67. Bomer N., Beverborg N.G., Hoes M.F. et al. Selenium and outcome in heart failure. Eur J Heart Fail. 2020; 22 (8): 1415–23. DOI: 10.1002/ejhf.1644
  68. Vaassen M.M. Manual Lymph Drainage in a Patient with Congestive Heart Failure: A Case Study. Ostomy Wound Manage. 2015; 61 (10): 38–45.
  69. Krysztofiak H., Wleklik M., Migaj J. et al. Cardiac Cachexia: A Well-Known but Challenging Complication of Heart Failure. Clin Interv Aging. 2020; 15: 2041–51. DOI: 10.2147/CIA.S273967
  70. Okoshi M.P., Capalbo R.V., Romeiro F.G. et al. Cardiac Cachexia: Perspectives for Prevention and Treatment. Arq Bras Cardiol. 2017; 108 (1): 74–80. DOI: 10.5935/abc.20160142
  71. Zhang Z.H., Meng F.Q., Hou X.F. et al. Clinical characteristics and long-term prognosis of ischemic and non-ischemic cardiomyopathy. Indian Heart J. 2020; 72 (2): 93–100. DOI: 10.1016/j.ihj.2020.04.004
  72. Cohn J.N. Unloading the failing heart. Previous experience and future directions. Am J Hypertens. 1989; 2 (9): 736-739.
  73. Kobayashi M., Voors A.A., Girerd N. et al. Heart failure etiologies and clinical factors precipitating for worsening heart failure: Findings from BIOSTAT-CHF. Eur J Intern Med. 2020; 71: 62–9. DOI: 10.1016/j.ejim.2019.10.017
  74. Vinogradova N.G., Polyakov D.S., Fomin I.V. et al. Prognosis of the life of patients with chronic heart failure and atrial fibrilla-tion, depending on the control of hemodynamic parameters and tolerance to physical exertion in the background of basic therapy. Kardiologiia. 2019; 59 (4S): 51–8 (in Russ.). DOI: 10.18087/cardio.2622